Company Profile - Syncona Ltd

Introduction

Syncona Ltd (Syncona) is a closed-ended investment company. Its services include founding, building, and funding companies. The company makes investments in life sciences companies including gene therapy, cell therapy, biologics, and small molecule fields. Syncona’s portfolio companies include Freeline Therapeutics, SwanBio Therapeutics, Neogene Therapeutics, Autolus, Quell Therapeutics, Anveon, Achilles Therapeutics, Clade Therapeutics, Purespring Therapeutics, OMass Therapeutics, and Resolution Therapeutics. The company also provides Syncona Platform which helps to transform scientific research into companies. It serves healthcare, biotechnology, pharmaceutical, life sciences, and other sectors. The company operates in the UK, the US and Switzerland. Syncona is headquartered in Saint Peter Port, Guernsey, the UK.